HHC-acetate |
|
[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-yl] acetate
|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
|
| Formula | C23H34O3 |
|---|
| Molar mass | 358.522 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
CCCCCC1=CC2=C([C@@H]3CC(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)C
|
InChI=1S/C23H34O3/c1-6-7-8-9-17-13-20(25-16(3)24)22-18-12-15(2)10-11-19(18)23(4,5)26-21(22)14-17/h13-15,18-19H,6-12H2,1-5H3/t15?,18-,19-/m1/s1 Key:ZAZIHGFBNRVMAI-JCNKGUCWSA-N
|
HHC-acetate (hexahydrocannabinol-O-acetate, HHC-O) is a semi-synthetic cannabinoid derivative which has been marketed since around 2022.